Palantir Stock Holds at $136.88 as 154x P/E Limits Upside
Palantir stock at $136.88 was rated a hold as its 154x trailing P/E capped upside despite 70% revenue growth. For holders, the debate is no longer whether the company is expanding, but whether the valuation already prices in another year of near-perfect execution.
Palantir’s 70% Revenue Surge
70% revenue growth in Q4 2025 pushed sales to $1.406 billion, while U.S. commercial revenue jumped 137% and the Rule of 40 score hit 127. Alex Karp called the company “an n of 1,” a description that fits the pace of growth but not the price investors are paying for it.
61% revenue growth is the 2026 guide, along with at least 115% U.S. commercial growth and free cash flow of $3.93 billion to $4.13 billion. That keeps the operating story intact for investors who want acceleration, but it also sets a high bar for every quarter that follows.
Palantir Valuation at 154x
154x trailing P/E is where the hold call turns from business momentum to valuation math. Palantir also trades at 94 forward P/E, while its free cash flow yield is under 1%, a mix that leaves little room for disappointment if growth cools or margins slip.
$684 million in stock-based compensation for FY 2025 and net selling across 21 recent transactions add another wrinkle. Those figures do not change the growth story, but they do show that shareholders are not the only ones locking in value after the run.
$136.88 Price Versus Targets
10.31% is how much Palantir stock fell in the past month, and it is down 22.99% year to date even as the S&P 500 is up roughly 9% over the same stretch. The gap says the market has already pushed back on the idea that strong growth alone can carry the multiple higher.
$183.73 is the analyst consensus target, and $152.44 is the AI fair-value model’s base case. Even with those levels above the current price, the stock still has to earn a premium multiple by matching the kind of execution its valuation assumes.
24% is the Polymarket crowd’s probability for $126 in May, while only roughly 15% is assigned in combined probability to prices above $150. That split leaves Palantir in a narrow lane: deliver another outsized year, or risk a stock that already reflects the best-case version of the story.
